EOLS

Dopo l'orario di chiusura: 10.89

Evolus Inc (EOLS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1176)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

Prossima data di guadagno

Ultimi documenti SEC

EOLS's Discussions on Twitter

Confronta EOLS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EOLS Evolus Inc	10.89	689.57M	202.09M	-61.69M	-35.64M	-1.08
ZTS Zoetis Inc	164.84	74.37B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.69	43.81B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	22.09	25.03B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	12.52	14.94B	15.05B	-883.30M	1.89B	-0.74

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-29	Aggiornamento	Barclays	Equal Weight → Overweight
2022-06-23	Iniziato	Needham	Buy
2022-05-12	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-20	Aggiornamento	Truist	Hold → Buy
2021-05-06	Aggiornamento	Mizuho	Neutral → Buy
2021-04-08	Reiterato	H.C. Wainwright	Buy
2021-02-24	Downgrade	Truist	Buy → Hold
2020-07-07	Downgrade	Mizuho	Buy → Neutral
2020-02-06	Ripresa	Mizuho	Buy
2019-11-26	Iniziato	SVB Leerink	Outperform
2019-09-05	Ripresa	Mizuho	Buy
2019-06-28	Iniziato	Wells Fargo	Market Perform
2019-06-11	Iniziato	Barclays	Underweight
2019-03-20	Iniziato	SunTrust	Buy
2019-02-14	Iniziato	H.C. Wainwright	Buy
2019-01-29	Iniziato	Stifel	Buy

Mostra tutto

Evolus Inc Borsa (EOLS) Ultime notizie

Evolus Inc Azioni (EOLS) Dati Finanziari

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

Confronta EOLS con altri titoli

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc Borsa (EOLS) Ultime notizie

Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability - Yahoo Finance

Lord Abbett & CO. LLC Acquires 188,685 Shares of Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Stock Options Galore! Discover Evolus’ Latest Move - Jomfruland.net

(EOLS) On The My Stocks Page - Stock Traders Daily

Evolus Expands Team with Strategic Equity Incentives Package for 20 New Hires - StockTitan

Evolus's SWOT analysis: aesthetics firm's stock poised for growth By Investing.com - Investing.com South Africa

Evolus's SWOT analysis: aesthetics firm's stock poised for growth - Investing.com

Charles Schwab Investment Management Inc. Buys 265,635 Shares of Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Evolus, Inc. (NASDAQ:EOLS) Is Expected To Breakeven In The Near Future - Simply Wall St

212,209 Shares in Evolus, Inc. (NASDAQ:EOLS) Acquired by Walleye Capital LLC - MarketBeat

Connor Clark & Lunn Investment Management Ltd. Takes $940,000 Position in Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Great Point Partners LLC Has $18.95 Million Stock Holdings in Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Jeffrey Plumer: Defending a ‘Whole New World’ - Orange County Business Journal

When (EOLS) Moves Investors should Listen - Stock Traders Daily

Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher - MSN

Evolus, Inc. (NASDAQ:EOLS) Short Interest Up 8.8% in October - MarketBeat

OC500 2024: Sandra Beaver - Orange County Business Journal

Behind the Bell: Evolus - Nasdaq

Perceptive Advisors LLC Adjusts Stake in Evolus Inc - GuruFocus.com

Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) - Yahoo Finance

Stonepine Capital Management Reduces Stake in Evolus Inc - GuruFocus.com

Evolus, Inc. (NASDAQ:EOLS) Might Not Be As Mispriced As It Looks After Plunging 26% - Simply Wall St

Evolus, Inc. (NASDAQ:EOLS) Position Increased by GSA Capital Partners LLP - MarketBeat

Evolus Inc (EOLS) Shares Gap Down to $12.58 on Nov 12 - GuruFocus.com

Evolus Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates - MSN

Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance

Evolus, Inc. (NASDAQ:EOLS) Q3 2024 Earnings Call Transcript - Insider Monkey

Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges By GuruFocus - Investing.com Canada

Evolus (NASDAQ:EOLS) Shares Gap Down on Disappointing Earnings - MarketBeat

Evolus' (EOLS) Buy Rating Reiterated at HC Wainwright - MarketBeat

Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges - GuruFocus.com

Evolus earnings missed by $0.18, revenue fell short of estimates - Investing.com Canada

Evolus, Inc. Reports Strong Q3 2024 Growth - TipRanks

Evolus Reports Third Quarter 2024 Results - Business Wire

Injections For Your Frown Lines Cost Just $49, Thanks To This Membership Club - The Zoe Report

Prescription Hair Loss and Hair Removal Drugs Market Projected To Witness Substantial Growth, 2024-2031: - EIN News

Evolus receives nod from EU for hyaluronic acid injectables, anticipates US approval - Healio

Evolus (NASDAQ:EOLS) Earns "Buy" Rating from HC Wainwright - MarketBeat

Evolus to Participate in Stifel 2024 Healthcare Conference - The Bakersfield Californian

Evolus, Inc. (NASDAQ:EOLS) Shares Purchased by Rice Hall James & Associates LLC - MarketBeat

Objective long/short (EOLS) Report - Stock Traders Daily

Evolus, Inc. Announces EU Approval of Estyme Injectable Hyaluronic Acid Gels Under New Medical Device Regulation - Marketscreener.com

Evolus Gets EU Approval for Treatment of Wrinkles - MarketWatch

Evolus gains EU certification for new dermal filler products - Investing.com

Evolus gains EU certification for new dermal filler products By Investing.com - Investing.com UK

Evolus Inc Azioni (EOLS) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a EOLS